Training | 2021.02.25
APT™ Formulation Combats Multi-Drug Resistant Candida auris: An Emerging Global Healthcare Threat
Candida auris is a multi-drug resistant fungus which can be fatal. There is up to a 55% mortality rate if C. auris enters a patients’ bloodstream. Recent studies conducted at Case Western Reserve University, using highly resistant strains of C. auris provided by the Centers for Disease Control (CDC), have demonstrated that APT™ based antifungal formulations are highly effective in killing this deadly fungus on skin surfaces. The APT™ formulations are the only known effective method that has the potential to remove C. auris from the skin of patients and healthcare workers.
(PRWeb February 25, 2021)
Read the full story at https://www.prweb.com/releases/apt_formulation_combats_multi_drug_resistant_candida_auris_an_emerging_global_healthcare_threat/prweb17744919.htm
For more information, please visit
https://www.prweb.com/releases/apt_formu[...]hcare_threat/prweb17744919.htm
